On November 11, 2025, Stride, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Virginia on behalf of investors who purchased or otherwise acquired Stride securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”).

On November 10, 2025, Telix Pharmaceuticals Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Indiana on behalf of investors who purchased or otherwise
acquired publicly traded Telix securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”).

On November 6, 2025, Inspire Medical Systems, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Minnesota on behalf of investors who purchased or otherwise acquired the common stock of Inspire between August 6, 2024 through August 4, 2025, inclusive (the “Class Period”).

On November 5, 2025, Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of New York on behalf of investors who purchased or acquired Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. (“Six Flags” or the “Company”) common stock pursuant and/or traceable to the Company’s Registration Statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six Flags”) with Cedar Fair, L.P. (“Cedar Fair”), and their subsidiaries and affiliates.

On November 4, 2025, Fiserv, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Wisconsin on behalf of investors who purchased or otherwise acquired Fiserv securities between July 23, 2025 and October 29, 2025, inclusive (the “Class Period”).

On November 3, 2025, CarMax, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Maryland on behalf of investors who purchased or otherwise acquired publicly traded CarMax securities between June 20, 2025 and September 24, 2025, inclusive (the “Class Period”).

On October 31, 2025, AMC Entertainment Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired AMC Entertainment Holdings, Inc. (“AMC” or the “Company”) Preferred Equity Units (“APEs”) during the Class Period including those who held APEs immediately prior to the conversion of APEs to common stock on August 25, 2023 and were thereby excluded from receiving the Special Dividend issued to common shareholders on August 28, 2023.

On October 31, 2025, Synopsys, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Synopsys securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”).

On October 30, 2025, Avantor, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased or otherwise acquired Avantor common stock between March 5, 2024, and October 28, 2025, inclusive (the “Class Period”).

On October 29, 2025, The Wildermuth Fund (a.k.a. the Wildermuth Endowment Fund and Wildermuth Endowment Strategy Fund) and other Defendants were sued for violations of the federal securities laws in the United States District Court for the Southern District of New Jersey on behalf of investors who purchased Class A (WESFX), Class C (WEFCX), and/or Class I (WEIFX) shares in the Wildermuth Fund from November 1, 2020 through June 29, 2023, inclusive (the “Class Period”).

On October 27, 2025, DexCom, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired DexCom securities between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”).

On October 24, 2025, James Hardie Industries plc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Illinois on behalf of investors who purchased, or otherwise acquired, James Hardie common stock (previously American Depositary Shares until their conversion to common stock on July 1, 2025) during the period from May 20, 2025 through August 18, 2025, inclusive (the “Class Period”).

On October 23, 2025, a lawsuit was filed in Delaware Court of Chancery against Ocugen, Inc. by Plaintiff for breach of contract and seeks to void the Charter Amendment, which was not validly approved by the holders of a majority of Ocugen shares “entitled to vote generally in the election of directors” at the Annual Meeting.Plaintiff also seeks relief under 8 Del. C. § 225(b), declaring that stockholders did not approve the Charter Amendment at the Annual Meeting. Finally, Plaintiff seeks a permanent injunction barring the Company from issuing unauthorized shares, as well as a declaration that the Correction Certificate is invalid and without effect, as it does not accord with applicable law.

On October 17, 2025, a shareholder derivative action was filed in Delaware Court of Chancery by Plaintiff individually and on behalf of Envestnet, Inc.arising from a conflicted transaction whereby funds associated with Bain Capital Private Equity, LP (collectively, “Bain”) purchased the outstanding shares of the Company in a take-private merger for $63.15 per share in cash (the “Merger”).

On October 16, 2025, Baxter International, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Illinois on behalf of investors who purchased or otherwise acquired Baxter common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

On October 15, 2025, MoonLake Immunotherapeutics was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Defendant MoonLake Immunotherapeutics (“MoonLake” or the “Company”) common stock between March 10, 2024 through September 29, 2025, inclusive (the “Class Period”).

On October 14, 2025, Exxon Mobil Corporation was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of all shareholders who held Exxon Mobil shares during the time beginning not later than September 15, 2025 (or such earlier date that disclosure or solicitiation concerning the Exxon Retail Voting Program was made) and continuing until Exxon takes appropriate corective action and terminates the RVP.

On October 9, 2025, aTyr Pharma, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of California on behalf of investors who purchased or otherwise acquired aTyr common stock between January 16, 2025, and September 12, 2025, inclusive (the “Class Period”).

On October 9, 2025, WPP plc was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired WPP common stock between February 27, 2025, to July 8, 2025, inclusive (the “Class Period”).

On October 9, 2025, Marex Group plc was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Marex securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”).